Imipenem
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitoring (NCT03790631) | University of Geneva, Switzerland | 2019-01-14 |
| Antibacterial Prophylaxis vs no Prophylaxis for Hematological Malignancies Patients Before Allo-HSCT (NCT03733340) | Nanfang Hospital, Southern Medical University | 2018-12-01 |
Track Imipenem automatically
Every clearance here is in the API, with alerts when new ones post.